Literature DB >> 21795756

Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease.

George C Kosmadakis1, Stephen G John, Emma L Clapp, Joao L Viana, Alice C Smith, Nicolette C Bishop, Alan Bevington, Paul J Owen, Christopher W McIntyre, John Feehally.   

Abstract

BACKGROUND: There is increasing evidence of the benefit of regular physical exercise in a number of long-term conditions including chronic kidney disease (CKD). In CKD, this evidence has mostly come from studies in end stage patients receiving regular dialysis. There is little evidence in pre-dialysis patients with CKD Stages 4 and 5.
METHODS: A prospective study compared the benefits of 6 months regular walking in 40 pre-dialysis patients with CKD Stages 4 and 5. Twenty of them were the exercising group and were compared to 20 patients who were continuing with usual physical activity. In addition, the 40 patients were randomized to receive additional oral sodium bicarbonate (target venous bicarbonate 29 mmol/L) or continue with previous sodium bicarbonate treatment (target 24 mmol/L).
RESULTS: Improvements noted after 1 month were sustained to 6 months in the 18 of 20 who completed the exercise study. These included improvements in exercise tolerance (reduced exertion to achieve the same activity), weight loss, improved cardiovascular reactivity, avoiding an increase in blood pressure medication and improvements in quality of health and life and uraemic symptom scores assessed by questionnaire. Sodium bicarbonate supplementation did not produce any significant alterations.
CONCLUSIONS: This study provides further support for the broad benefits of aerobic physical exercise in CKD. More studies are needed to understand the mechanisms of these benefits, to study whether resistance exercise will add to the benefit and to evaluate strategies to promote sustained lifestyle changes, that could ensure continued increase in habitual daily physical activity levels.

Entities:  

Mesh:

Year:  2011        PMID: 21795756     DOI: 10.1093/ndt/gfr364

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  28 in total

1.  The effectiveness and safety of modest exercise in Japanese patients with chronic kidney disease: a single-armed interventional study.

Authors:  Masami Hamada; Yoshinari Yasuda; Sawako Kato; Hiroki Arafuka; Motomitsu Goto; Mutsuharu Hayashi; Etsuko Kajita; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2015-07-25       Impact factor: 2.801

Review 2.  Treatment rationale for coronary heart disease in advanced CKD.

Authors:  K Lopau; C Wanner
Journal:  Herz       Date:  2021-02-10       Impact factor: 1.443

3.  Exercise as an Adjunct Therapy In Chronic Kidney Disease.

Authors:  Danielle L Kirkman; David G Edwards; Shannon Lennon-Edwards
Journal:  Renal Nutr Forum       Date:  2014

4.  Evidence for anti-inflammatory effects of exercise in CKD.

Authors:  João L Viana; George C Kosmadakis; Emma L Watson; Alan Bevington; John Feehally; Nicolette C Bishop; Alice C Smith
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

5.  Aerobic exercise in adults with chronic kidney disease (CKD): a meta-analysis.

Authors:  Gaiqin Pei; Yi Tang; Li Tan; Jiaxing Tan; Long Ge; Wei Qin
Journal:  Int Urol Nephrol       Date:  2019-07-22       Impact factor: 2.370

6.  Clinical practice guideline exercise and lifestyle in chronic kidney disease.

Authors:  Luke A Baker; Daniel S March; Thomas J Wilkinson; Roseanne E Billany; Nicolette C Bishop; Ellen M Castle; Joseph Chilcot; Mark D Davies; Matthew P M Graham-Brown; Sharlene A Greenwood; Naushad A Junglee; Archontissa M Kanavaki; Courtney J Lightfoot; Jamie H Macdonald; Gabriella M K Rossetti; Alice C Smith; James O Burton
Journal:  BMC Nephrol       Date:  2022-02-22       Impact factor: 2.388

7.  Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression.

Authors:  Emma L Watson; George C Kosmadakis; Alice C Smith; Joao L Viana; Jeremy R Brown; Karen Molyneux; Izabella Z A Pawluczyk; Michael Mulheran; Nicolette C Bishop; Susan Shirreffs; Ronald J Maughan; Paul J Owen; Stephen G John; Christopher W McIntyre; John Feehally; Alan Bevington
Journal:  Eur J Appl Physiol       Date:  2013-04-17       Impact factor: 3.078

8.  Akt1-mediated fast/glycolytic skeletal muscle growth attenuates renal damage in experimental kidney disease.

Authors:  Shinsuke Hanatani; Yasuhiro Izumiya; Satoshi Araki; Taku Rokutanda; Yuichi Kimura; Kenneth Walsh; Hisao Ogawa
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

Review 9.  Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies.

Authors:  Danielle L Kirkman; Natalie Bohmke; Salvatore Carbone; Ryan S Garten; Paula Rodriguez-Miguelez; Robert L Franco; Jason M Kidd; Antonio Abbate
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

Review 10.  The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review.

Authors:  Heather J MacKinnon; Thomas J Wilkinson; Amy L Clarke; Douglas W Gould; Thomas F O'Sullivan; Soteris Xenophontos; Emma L Watson; Sally J Singh; Alice C Smith
Journal:  Ther Adv Chronic Dis       Date:  2018-07-04       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.